These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 17071407)

  • 21. Role of mitogen-activated protein kinase kinase kinases in signal integration.
    Cuevas BD; Abell AN; Johnson GL
    Oncogene; 2007 May; 26(22):3159-71. PubMed ID: 17496913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HOXA1-stimulated oncogenicity is mediated by selective upregulation of components of the p44/42 MAP kinase pathway in human mammary carcinoma cells.
    Mohankumar KM; Xu XQ; Zhu T; Kannan N; Miller LD; Liu ET; Gluckman PD; Sukumar S; Emerald BS; Lobie PE
    Oncogene; 2007 Jun; 26(27):3998-4008. PubMed ID: 17213808
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MAPK signaling pathways in the regulation of hematopoiesis.
    Geest CR; Coffer PJ
    J Leukoc Biol; 2009 Aug; 86(2):237-50. PubMed ID: 19498045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of TNF mediated antiapoptotic signaling in human neutrophils: role of delta-PKC and ERK1/2.
    Kilpatrick LE; Sun S; Mackie D; Baik F; Li H; Korchak HM
    J Leukoc Biol; 2006 Dec; 80(6):1512-21. PubMed ID: 17138860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PrPC-related signal transduction is influenced by copper, membrane integrity and the alpha cleavage site.
    Haigh CL; Lewis VA; Vella LJ; Masters CL; Hill AF; Lawson VA; Collins SJ
    Cell Res; 2009 Sep; 19(9):1062-78. PubMed ID: 19597535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
    Yang R; Piperdi S; Gorlick R
    Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of BRAF/MEK/MAP kinase pathway restores expression of iodide-metabolizing genes in thyroid cells expressing the V600E BRAF mutant.
    Liu D; Hu S; Hou P; Jiang D; Condouris S; Xing M
    Clin Cancer Res; 2007 Feb; 13(4):1341-9. PubMed ID: 17317846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.
    Shukla A; Grisouard J; Ehemann V; Hermani A; Enzmann H; Mayer D
    Endocr Relat Cancer; 2009 Jun; 16(2):429-41. PubMed ID: 19153208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro.
    Toulany M; Dittmann K; Fehrenbacher B; Schaller M; Baumann M; Rodemann HP
    DNA Repair (Amst); 2008 Oct; 7(10):1746-56. PubMed ID: 18678286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor-beta 1 impairs endothelin-1-mediated contraction of brain vessels by inducing mitogen-activated protein (MAP) kinase phosphatase-1 and inhibiting p38 MAP kinase.
    Tong XK; Hamel E
    Mol Pharmacol; 2007 Dec; 72(6):1476-83. PubMed ID: 17848599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
    Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
    Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene regulation by MAP kinase cascades.
    Fiil BK; Petersen K; Petersen M; Mundy J
    Curr Opin Plant Biol; 2009 Oct; 12(5):615-21. PubMed ID: 19716758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of p38 mitogen-activated protein kinase is required for death receptor-independent caspase-8 activation and cell death in response to sphingosine.
    Yoon CH; Kim MJ; Park MT; Byun JY; Choi YH; Yoo HS; Lee YM; Hyun JW; Lee SJ
    Mol Cancer Res; 2009 Mar; 7(3):361-70. PubMed ID: 19276187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorescent and bioluminescent protein-fragment complementation assays in the study of G protein-coupled receptor oligomerization and signaling.
    Vidi PA; Watts VJ
    Mol Pharmacol; 2009 Apr; 75(4):733-9. PubMed ID: 19141658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic analysis of complex signal transduction pathways using protein fragment complementation assays.
    Koblizek TI; Siehoff A; Pitt A
    Methods Mol Biol; 2013; 986():179-85. PubMed ID: 23436413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Universal strategies in research and drug discovery based on protein-fragment complementation assays.
    Michnick SW; Ear PH; Manderson EN; Remy I; Stefan E
    Nat Rev Drug Discov; 2007 Jul; 6(7):569-82. PubMed ID: 17599086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzyme fragment complementation: a flexible high throughput screening assay technology.
    Eglen RM
    Assay Drug Dev Technol; 2002 Nov; 1(1 Pt 1):97-104. PubMed ID: 15090161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visualization of the spatial and temporal dynamics of MAPK signaling using fluorescence imaging techniques.
    Tomida T
    J Physiol Sci; 2015 Jan; 65(1):37-49. PubMed ID: 25145828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploiting network biology to improve drug discovery.
    MacDonald ML; Westwick JK
    Methods Mol Biol; 2007; 356():221-32. PubMed ID: 16988406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein fragment complementation strategies for biochemical network mapping.
    Michnick SW
    Curr Opin Biotechnol; 2003 Dec; 14(6):610-7. PubMed ID: 14662390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.